HTT and Huntington's Disease: A Near-Perfect Test Exists. Most People At Risk Still Say No.

Most of the genes covered on this site are worth testing for because early knowledge leads to early action — a screening schedule, a drug to avoid, a lifestyle change. HTT and Huntington's disease sit in a fundamentally different category, and it's exactly what makes the gene so instructive: there is currently no treatment that stops or slows the disease. The test tells you your future with extraordinary precision. What you do with that information is an entirely separate, deeply personal question — and most people, when given the choice, choose not to ask.

What HTT Does, and What Goes Wrong

The HTT gene contains a repeating three-letter DNA sequence (CAG) near its start. Everyone has some number of these repeats — it's a completely normal part of the gene. Huntington's disease occurs when that repeat expands beyond a threshold, producing an abnormal version of the huntingtin protein that gradually damages neurons, particularly in brain regions that control movement, cognition, and behavior. It's an autosomal dominant condition: one expanded copy from either parent is enough, and each child of an affected parent has a 50% chance of inheriting it.

Symptoms — involuntary movements, cognitive decline, and psychiatric changes — typically begin in mid-adulthood, often between ages 30 and 50, though the exact age of onset varies and tends to correlate with the length of the repeat expansion. There is currently no treatment that halts or reverses the underlying neurodegeneration, though symptom management has improved over time.

The Test Itself Is About as Accurate as Genetic Testing Gets

Since the HTT gene was identified in 1993, direct genetic testing has offered sensitivity and specificity approaching 100% — a level of predictive certainty that's rare in medicine generally, let alone genetics. Unlike a risk score or a probability, a Huntington's predictive test gives something close to a definitive yes-or-no answer about a person's genetic future, decades before any symptoms would appear.

Why So Few People Choose to Find Out

Researchers who study this decision point to a mix of factors: the absence of any disease-modifying treatment removes the "actionability" that motivates testing for many other conditions; anxiety about receiving devastating news; concerns about the impact on insurance, employment, or family relationships; and, for many, a genuine preference to live without a known countdown rather than with one. None of these are irrational responses — they reflect a real, carefully considered trade-off that genetics as a field has had to take seriously.

The Counseling Model Huntington's Testing Built

Because of the psychological weight involved, Huntington's predictive testing pioneered a counseling protocol that's now used as a template for other high-stakes genetic tests: mandatory pre-test counseling with a geneticist and often a psychologist, a waiting period between counseling and the actual blood draw, and structured psychological support built into the post-result process regardless of outcome. This model exists because early researchers took seriously the idea that a genetic result this consequential shouldn't be delivered the way a routine lab result is.

Why the Landscape May Be Starting to Shift

Reports from more recent years suggest uptake may be increasing in some countries — one likely factor is that Huntington's disease research has moved further into active clinical trials for gene-targeting and huntingtin-lowering therapies than at any point in the gene's history. As the field edges closer to treatments that could genuinely change the disease trajectory, the calculus around testing may shift too — knowing early becomes more valuable when there's eventually something to do with the information beyond planning.